Skip to main navigation Skip to search Skip to main content

ROS1+ in vitro models: two new patient-derived NSCLC cell lines

  • Dexeus University Hospital, Pangaea Oncology
  • Quirón Dexeus University Hospital, Dr Rosell Oncology Institute
  • University of Groningen, University Medical Center Groningen, Department of Pulmonology
  • University of Groningen, University Medical Center Groningen, Department of Pathology and Medical Biology

Research output: Contribution to conference › Poster › Academic

150 Downloads (Pure)
Original languageEnglish
Number of pages1
Publication statusPublished - 17 Jun 2025
EventEuropean Association for Cancer Research 2025 - Lisbon, Portugal
Duration: 16 Jun 2025 → 19 Jun 2025

Conference

ConferenceEuropean Association for Cancer Research 2025
Abbreviated titleEACR2025
Country/TerritoryPortugal
CityLisbon
Period16/06/25 → 19/06/25

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 03 - Good Health and Well-being
    SDG 03 Good Health and Well-being

Keywords

  • ROS1
  • ROS1 inhibitors
  • patient derived cell lines

Research Focus Areas Hanze University of Applied Sciences * (mandatory by Hanze)

  • Healthy Ageing

Research Focus Areas Research Centre or Centre of Expertise * (mandatory by Hanze)

  • Medical Diagnostics & Point of Care Testing
  • Healthcare & Biotechnology

Publinova themes

  • Health

Cite this